Osiris Therapeutics IncAdd to My Watchlist

OSIR:USNASDAQ GMIndustry: Therapeutics
  • 17.31
  • 0.27  -1.54%
    Today's Change
  • 17.58
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 4/1/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding34 million
Market Cap$595 million
Return on Equity ttm-2.17%
Last DividendOSIR:US does not pay a dividend
EPS: Year Actual ttm-0.019
EPS: Year Est. 12/15 ttm0.305
EPS: Quarterly Actual 12/14 0.03
EPS: Quarterly Est. 3/15 0.00
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate75.00
Company Description
Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.
Revenue$60 million
Net Income$-2 million
Total Assets$98 million
Web Sitewww.Osiris.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!